γ-tocopherol, the new vitamin E?

American Journal of Clinical Nutrition

Volumn 77, Issue 3, 2003, Pages 530-531

  Devaraj, Sridevi ^a   Traber, Maret G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONATE 5 LIPOXYGENASE; ASCORBIC ACID; BETA CAROTENE; GAMMA TOCOPHEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; ISOPROSTANE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG POTENCY; EDITORIAL; ENZYME INHIBITION; HEMOSTASIS; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LUNG CANCER; MALE; MONOCYTE; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATIENT COMPLIANCE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; TREATMENT CONTRAINDICATION; VASODILATATION;

ANIMALIA;

EID: 0037369596     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.3.530     Document Type: Editorial

References (15)

1. Kaul N, Devaraj S, Jialal I. Alpha tocopherol and atherosclerosis. Exp Biol Med 2001;226:5-12.
2. Devaraj S, Jialal I. The effects of alpha tocopherol on crucial cells in atherogenesis. Curr Opin Lipidol 1998;9:11-5.
3. Ricciarelli R, Tasinato A, Clement S. Ozer NK, Boscoboinik D, Azzi A. α-Tocopherol specifically inactivates cellular protein kinase α by changing its phosphorylation state. Biochem J 1998; 334:243-9.
4. Keaney JF Jr, Simon DI, Freedman JE. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J 1999;13:965-75.
5. Heitzer T, Yla Herttuala S, Wild E, Luoma J, Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J Am Coll Cardiol 1999; 33:499-505.
6. Jialal I, Devaraj S. Antioxidants and atherosclerosis - don't throw out the baby with the bathwater (editorial). Circulation (in press).
7. Handelman GJ, Machlin LJ, Fitch K, Weiter JJ, Dratz EA. Oral α-tocopherol supplements decrease plasma γ-tocopherol levels in humans. J Nutr 1985;115:807-13.
8. Traber MG. Vitamin E. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern nutrition in health and disease. Baltimore: Williams & Wilkins, 1999:347-62.
9. Ohrvall M, Sundlof G, Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 1996;239:111-7.
10. x and complements α-tocopherol: physiological implications. Proc Natl Acad Sci U S A 1997;94:3217-22.
11. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BM. γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and eptihelial cells. Proc Natl Acad Sci U S A 2000;97:11494-9.
12. Saldeen T, Li D, Mehta JL. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol 1999;34:1208-15.
13. Li D, Saldeen T, Romeo F, Mehta JL. Relative effects of alphaand gamma-tocopherol on low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats. J Cardiovasc Pharmacol Ther 1999;4: 219-26.
14. de Nigris F, Franconi F, Maida I, Palumbo G, Anania V, Napoli C. Modulation by alpha- and gamma-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells. Biochem Pharmacol 2000;59:1477-87.
15. Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 2003;77:700-6.